176 related articles for article (PubMed ID: 35251495)
1. An investigation on [5 fluorouracil and epigallocatechin-3-gallate] complex activity on HT-29 cell death and its stability in gastrointestinal fluid.
Moracci L; Sensi F; Biccari A; Crotti S; Gaio E; Benetti F; Traldi P; Pucciarelli S; Agostini M
Oncotarget; 2022; 13():476-489. PubMed ID: 35251495
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometry in the study of molecular complexes between 5-fluorouracil and catechins.
Moracci L; Crotti S; Traldi P; Agostini M
J Mass Spectrom; 2021 Jan; 56(1):e4682. PubMed ID: 33448570
[TBL] [Abstract][Full Text] [Related]
3. Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer.
Toden S; Tran HM; Tovar-Camargo OA; Okugawa Y; Goel A
Oncotarget; 2016 Mar; 7(13):16158-71. PubMed ID: 26930714
[TBL] [Abstract][Full Text] [Related]
4. Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells.
Chen C; Shen G; Hebbar V; Hu R; Owuor ED; Kong AN
Carcinogenesis; 2003 Aug; 24(8):1369-78. PubMed ID: 12819184
[TBL] [Abstract][Full Text] [Related]
5. (-)-Epigallocatechin Gallate (EGCG) Enhances the Sensitivity of Colorectal Cancer Cells to 5-FU by Inhibiting GRP78/NF-κB/miR-155-5p/MDR1 Pathway.
La X; Zhang L; Li Z; Li H; Yang Y
J Agric Food Chem; 2019 Mar; 67(9):2510-2518. PubMed ID: 30741544
[TBL] [Abstract][Full Text] [Related]
6. Targeting Lactate Dehydrogenase A with Catechin Resensitizes SNU620/5FU Gastric Cancer Cells to 5-Fluorouracil.
Han JH; Kim M; Kim HJ; Jang SB; Bae SJ; Lee IK; Ryu D; Ha KT
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065602
[TBL] [Abstract][Full Text] [Related]
7. Antiproliferative activity of tea catechins associated with casein micelles, using HT29 colon cancer cells.
Haratifar S; Meckling KA; Corredig M
J Dairy Sci; 2014 Feb; 97(2):672-8. PubMed ID: 24359816
[TBL] [Abstract][Full Text] [Related]
8. [Inhibitory effect and mechanism of (-)-epigallocatechin-3-gallate on HT29 and HCT-8 colorectal cancer cell lines and expression of HES1 and JAG1].
Zhang CX; Wang SM; Jin HY
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Aug; 14(8):636-9. PubMed ID: 21866461
[TBL] [Abstract][Full Text] [Related]
9. [Role and mechanism research on reversal of 5-fluorouracil resistance by epigallocatechin gallate in gastric cancer drug-resistance cells lines SGC-7901/5-FU].
Tang H; Zhang X; Cui S; Wang J; Ruan Q; Huang Y; Yang D
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Oct; 19(10):1170-1175. PubMed ID: 27781257
[TBL] [Abstract][Full Text] [Related]
10. Combination of 5-Florouracil and polyphenol EGCG exerts suppressive effects on oral cancer cells exposed to radiation.
Pons-Fuster López E; Gómez García F; López Jornet P
Arch Oral Biol; 2019 May; 101():8-12. PubMed ID: 30851692
[TBL] [Abstract][Full Text] [Related]
11. Integrated transcriptomic and metabolomic analyses to characterize the anti-cancer effects of (-)-epigallocatechin-3-gallate in human colon cancer cells.
Zhang Z; Zhang S; Yang J; Yi P; Xu P; Yi M; Peng W
Toxicol Appl Pharmacol; 2020 Aug; 401():115100. PubMed ID: 32512070
[TBL] [Abstract][Full Text] [Related]
12. Utilization of albumin fraction from defatted rice bran to stabilize and deliver (-)-epigallocatechin gallate.
Shi M; Wang ZS; Huang LY; Dong JJ; Zheng XQ; Lu JL; Liang YR; Ye JH
Food Chem; 2020 May; 311():125894. PubMed ID: 31787396
[TBL] [Abstract][Full Text] [Related]
13. Enhanced anti-colon cancer efficacy of 5-fluorouracil by epigallocatechin-3- gallate co-loaded in wheat germ agglutinin-conjugated nanoparticles.
Wang R; Huang J; Chen J; Yang M; Wang H; Qiao H; Chen Z; Hu L; Di L; Li J
Nanomedicine; 2019 Oct; 21():102068. PubMed ID: 31374249
[TBL] [Abstract][Full Text] [Related]
14. Interaction of tea polyphenols and food constituents with model gut epithelia: the protective role of the mucus gel layer.
D'Agostino EM; Rossetti D; Atkins D; Ferdinando D; Yakubov GE
J Agric Food Chem; 2012 Mar; 60(12):3318-28. PubMed ID: 22364573
[TBL] [Abstract][Full Text] [Related]
15. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells.
Shimizu M; Deguchi A; Lim JT; Moriwaki H; Kopelovich L; Weinstein IB
Clin Cancer Res; 2005 Apr; 11(7):2735-46. PubMed ID: 15814656
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of a combination of dietary factors sulforaphane and (-) epigallocatechin-3-gallate in HT-29 AP-1 human colon carcinoma cells.
Nair S; Hebbar V; Shen G; Gopalakrishnan A; Khor TO; Yu S; Xu C; Kong AN
Pharm Res; 2008 Feb; 25(2):387-99. PubMed ID: 17657594
[TBL] [Abstract][Full Text] [Related]
17. Chemosensitization of HT29 and HT29-5FU Cell Lines by a Combination of a Multi-Tyrosine Kinase Inhibitor and 5FU Downregulates ABCC1 and Inhibits PIK3CA in Light of Their Importance in Saudi Colorectal Cancer.
Abdalla AN; Malki WH; Qattan A; Shahid I; Hossain MA; Ahmed M
Molecules; 2021 Jan; 26(2):. PubMed ID: 33440689
[TBL] [Abstract][Full Text] [Related]
18. Niosomes Consisting of Tween-60 and Cholesterol Improve the Chemical Stability and Antioxidant Activity of (-)-Epigallocatechin Gallate under Intestinal Tract Conditions.
Liang R; Chen L; Yokoyama W; Williams PA; Zhong F
J Agric Food Chem; 2016 Dec; 64(48):9180-9188. PubMed ID: 27933988
[TBL] [Abstract][Full Text] [Related]
19. Induction of Endoplasmic Reticulum Stress Pathway by Green Tea Epigallocatechin-3-Gallate (EGCG) in Colorectal Cancer Cells: Activation of PERK/p-eIF2
Md Nesran ZN; Shafie NH; Ishak AH; Mohd Esa N; Ismail A; Md Tohid SF
Biomed Res Int; 2019; 2019():3480569. PubMed ID: 31930117
[TBL] [Abstract][Full Text] [Related]
20. Protection of epigallocatechin gallate against degradation during in vitro digestion using apple pomace as a carrier.
Wu L; Sanguansri L; Augustin MA
J Agric Food Chem; 2014 Dec; 62(50):12265-70. PubMed ID: 25419979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
